Use of the UK General Practice Research Database for pharmacoepidemiology

British Journal of Clinical Pharmacology

Volumn 45, Issue 5, 1998, Pages 419-425

  García Rodríguez, Luis A ^a   Pérez Gutthann, Susanne ^b  

^a Department of Pharmacoepidemiology   (Spain)

^b Novartis Global Pharmacoepidemiology   (Spain)

Author keywords

Computerized healthcare databases; Pharmacoepidemiology; Pharmacovigilance; Research

Indexed keywords

DATA BASE; DRUG EFFICACY; DRUG SURVEILLANCE PROGRAM; GENERAL PRACTICE; HEALTH CARE; MEDICAL RECORD; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; RESEARCH; REVIEW; RISK BENEFIT ANALYSIS; UNITED KINGDOM;

DATABASES, FACTUAL; DRUG EVALUATION; DRUG MONITORING; GREAT BRITAIN; HUMANS; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; PHARMACOEPIDEMIOLOGY; RESEARCH;

EID: 7144259074     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1998.00701.x     Document Type: Review

References (29)

1. Sigler C, Cygan R, Van der Carr S. 1980 to 1990 English language bibliography of pharmacoepidemiologic research using computerized administrative databases. J Clin Res Pharmacoepid 1992; 6: 313-326.
2. Edlavitch S. Postmarketing Surveillance Methodologies. In Pharmacoepidemiology eds Hartzenia AG, Porta MS, Tilson HH, An introduction. Harvey Whitney Books 1991; 120.
3. Jick H, Madsen S, Nudelnian PM. Postmarketing follow-up at Group Health Cooperative of Puget Sound. Pharmacotherapy 1984; 4: 99-100.
4. Malcolm E, Downey W, Strand L, McNutt M, West R. Saskatchewan Health's linkable data bases and pharmacoepidemiology. PMS 1993; 6: 175-264.
5. Carson JL, Strom BL. Medicaid Databases. In Pharmacoepidemiology ed Strom BL, John Wiley & Sons 1994; 199.
6. Ray WA, Griffin MR. Use of Medicaid data for pharmacoepidemiology. Am J Epidemiol 1989; 129: 837-849.
7. Friedman GD. Kaiser Permanente Medical Care Program: Northern California and other regions. In Pharmacoepidemiology ed Strom BL, John Wiley & Sons 1994; 187.
8. Evans JMM, McMahon AD, McGilchrist MM, et al. Topical non-steroidal anti-inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: a record linkage case-control study. Br Med J 1995; 311: 22-26.
9. Herings RMC, Stricker BHCH, Nap G, Bakker A. Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy-based exposure cohorts. J Epidemiol Community Health 1992; 46: 136-140.
10. Garcí Rodríguez LA, Cattaruzzi C, Troncon MG, Agostinis L. Risk of hospitalization for upper gastrointestinal bleeding associated with ketorolac, other NSAIDs, calcium antagonists and other antihypertensive drugs. Arch Int Med 1997 (in press).
11. Gaist D, Hallas J, Hansen NC, Gram LF. Are young adults with asthma treated sufficiently with inhaled steroids? A population-based study of prescription data from 1991 and 1994. Br J Pharmacol 1996; 41: 285-289.
12. Hollowell J. The General Practice Research Database: quality of morbidity data. Population Trends 1997: 36-40.
13. Walley T, Mantgani A. The UK General Practice Research Database. Lancet 1997; 350: 1097-1099.
14. Cohen MR. Compilation of abstracts and index published by the Boston Collaborative Surveillance Program 1966-1985. Hosp Pharm 1986; 21: 497-559.
15. Jick H, Vessey M. Case-control studies in the evaluation of drug-induced illness. Am J Epidemiol 1978; 107: 1-7.
16. Jick H. A major resource for drug safety studies. The General Practice Research Database. Carshalton: Centre for Medicines Reasearch 1995.
17. Perry J (ed). Oxmis problem codes for primary medical care. Oxford, Headington 1978.
18. Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. Br Med J 1991; 302: 766-768.
19. Jick H, Terris BZ, Derby LE, Jick SS. Further validation of information recorded on a general practitioner based computerised data resource in the United Kingdom. Pharmacoepidemiol Drug Safety 1992; 1: 347-349.
20. Jick SS, Terris BZ. Anticonvulsants and congenital malformations. Pharmacotherapy 1997; 17: 561-564.
21. Key Health Statistics from General Practice. Studies on Medical and Population Subjects, No. 60. The Stationery Office, London 1996.
22. Strom BL, Carson JL, Halpern AC, Schinnar R, Snyder RS, Stolley PD. Using a claims database to investigate drug-induced Stevens-Johnson syndrome. Stat Med 1991; 10: 656-676.
23. Garcia Rodriguez LA, Ruigómez A, Jick H. A review of epidemiologic research on drug-induced acute liver injury using the General Practice Research Database in the U.K. Pharmacotherapy 1997; 17: 721-728.
24. García Rodríguez LA, Stricker BH, Zimmerman HJ. Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid. Arch Intern Med 1996; 156: 1327-1332.
25. MCA/CSM. Revised indications for co-amoxiclav (Augmentin). Current Problems in Pharmacovigilance 1997; 24: 4.
26. Jick H, Jick SS, Derby LE, Vasilakis C, Myers MW, Meier CR. Calcium channel blockers and cancer. Lancet 1997; 349: 525-528.
27. Olsen JH, Sorensen HT, Frits S, et al. Cancer risk in users of calcium channel blockers. Hypertension 1997; 29: 1091-1094.
28. Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet 1995; 346: 1589-1593.
29. Pérez Gutthann S, García Rodríguez LA, Castellsague Pique J, Duque Oliart A. Hormone replacement therapy and risk of venous thromboembolism: population based case-control study. Br Med J 1997; 314: 796-800.